Glucosinolates are amino acid-derived secondary metabolites with diverse biological activities dependent on chemical modifications of the side chain. Five flavin-monooxygenases FMO GS-OX1-5 have recently been identified as aliphatic glucosinolate side chain modification enzymes in Arabidopsis thaliana that catalyse the generation of methylsulphinylalkyl glucosinolates, which can be hydrolysed to products with distinctive benefits for human health and plant defence. Though the localization of most aliphatic glucosinolate biosynthetic enzymes has been determined, little is known about where the side chain modifications take place despite their importance. Hence, the spatial expression pattern of FMO GS-OX1-5 genes in Arabidopsis was investigated by expressing green fluorescent protein (GFP) and b-glucuronidase (GUS) fusion genes controlled by FMO GS-OX1-5 promoters. The cellular compartmentation of FMO GS-OX1 was also detected by transiently expressing a FMO GS-OX1 -yellow fluorescent protein (YFP) fusion protein in tobacco leaves. The results showed that FMO GS-OX1-5 were expressed basically in vascular tissues, especially in phloem cells, like other glucosinolate biosynthetic genes. They were also found in endodermis-like cells in flower stalk and epidermal cells in leaf, which is a location that has not been reported for other glucosinolate biosynthetic genes. It is suggested that the spatial expression pattern of FMO GS-OX1-5 determines the access of enzymes to their substrate and therefore affects the glucosinolate profile. FMO GS-OX1 -YFP fusion protein analysis identified FMO GS-OX1 as a cytosolic protein. Together with the subcellular locations of the other biosynthetic enzymes, an integrated map of the multicompartmentalized aliphatic glucosinolate biosynthetic pathway is discussed.
Introduction
Glucosinolates are amino acid-derived secondary metabolites present in the order Brassicales which includes the model plant Arabidopsis thaliana. Upon disruption of plant tissue by, for example, wounding or mastication, glucosinolates are hydrolysed by the thioglucosidases (myrosinases), which produce a range of breakdown products, primarily isothiocyanates and nitriles, with diverse biological activities (Bones and Rossiter, 2006; Halkier and Gershenzon, 2006; Zhang et al., 2006; Kissen and Bones, 2009 ). These breakdown products act as anti-microbials against pathogens, as feeding deterrents toward generalist herbivores, and as attractants for specialist herbivores (Tierens et al., 2001; . Some of the isothiocyanates hydrolysed from aliphatic methylsulphinylalkyl glucosinolates, such as 4-methylsulphinylbutyl glucosinolate, are considered to have cancer-preventive properties (Zhang et al., 1992;  Abbreviations: ER, endoplasmic reticulum; FMO, flavin-monooxygenase; GFP, green fluorescent protein; GUS, b-glucuronidase; YFP, yellow fluorescent protein.
ª The Author [2010] . Published by Oxford University Press [on behalf of the Society for Experimental Biology]. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com Rose et al., 2000 Rose et al., , 2005 Fahey et al., 2002; Talalay et al., 2007) and to be involved in plant defence. Aliphatic glucosinolates are derived from methionine and can be synthesized by three steps: (i) methionine chain elongation; (ii) glucosinolate core structure formation; and (iii) side chain modification. Modifications of the glucosinolate side chains are of particular importance because the biological activity of the glucosinolate hydrolysis products is determined to a large extent by the structure of the side chain. Five flavin-monooxygenases, FMO , have been identified as enzymes catalysing the first step in side chain modification of aliphatic glucosinolates, the S-oxygenation from methylthioalkyl to methylsulphinylalkyl glucosinolates (Hansen et al, 2007; Li et al., 2008) .
In the aliphatic glucosinolate biosynthetic pathway, most enzymes in the first two biosynthetic steps have been located to organs, tissue, and cells, or even in some cases to the subcellular level. Localization studies have been carried out for enzymes such as BCAT4 catalysing chain elongation (Schuster et al., 2006) , CYP79B2, CYP79F1, CYP79F2, and UGT74B1, involved in glucosinolate core structure formation (Mikkelsen et al., 2000; Reintanz et al., 2001; Tantikanjana et al., 2001; Grubb et al., 2004) , and the glucosinolate-specific transcription factors IQDI and OBP2 (Levy et al., 2005; Skirycz et al., 2006) . It was found that vascular bundles, in particular the phloem, were the centre of glucosinolate biosynthesis and regulation.
At the subcellular level, aliphatic glucosinolate biosynthesis involves reactions in the chloroplast, endoplasmatic reticulum (ER), and cytosol. Initial deamination catalysed by BCAT4 takes place in the cytosol (Schuster et al., 2006) . Side chain elongation enzymes such as MAMs are found in the chloroplasts (Textor et al., 2007) . Some downstream enzymes such as CYP79F1, CYP79F2, and CYP83A1 which catalyse core structure formation were shown to associate with ER membranes (Reintanz et al., 2001; Chen et al., 2003; Naur et al., 2003) and other enzymes including sulphotransferases that catalyse the final step of core structure formation were suggested to be sited in the cytosol (Klein et al., 2006) . Overall, knowledge about the location of aliphatic glucosinolate biosynthesis was established in studies of enzymes catalysing the early steps in the pathway. Very little has been reported on localization of the final biosynthetic step in side chain modification which determines the biological activity of glucosinolate hydrolysed products.
In this study, green fluorescent protein (GFP) and b-glucuronidase (GUS) reporter genes were used to examine the spatial expression pattern of the five FMO GS-OX genes. The fused GFP and GUS genes were expressed under the control of FMO GS-OX1-5 promoters. Fluorescence and GUS staining were analysed in different organs, tissues, and cell types. Expression of FMO GS-OX1-5 was observed in vascular tissue, in particular in the phloem, as seen for other biosynthetic genes (Mikkelsen et al., 2000; Reintanz et al., 2001; Levy et al., 2005; Schuster et al., 2006; Skirycz et al., 2006) . However, FMO GS-OX1-5 show specific spatial expression in epidermal cells of the leaf and endodermis-like cells of the flower stalk, which has not been reported for other biosynthetic genes.
The present results indicate that the spatial distribution pattern of FMO GS-OX1-5 might affect glucosinolate profiles by determining the access of enzymes to their substrates.
FMO GS-OX1 was discovered to be cytosolically localized, which might indicate that glucosinolate biosynthesis is performed by a complex pathway that relies on trafficking of intermediates between the chloroplast, ER, and cytosol. Based on the current work and previously reported biosynthetic enzymes, an integrated map of the multicompartmentalized aliphatic glucosinolate biosynthetic pathway was constructed.
Materials and methods
Plant material and growth condition Arabidopsis thaliana ecotype Columbia (Col-0) and tobacco (Nicotiana benthamiana) were used throughout this study. Plants were grown in a growth chamber at a photosynthetic flux of 100 lEi at 20°C and 70% relative humidity with a 16/8 h photoperiod.
Plasmid construction and transformation FMO GS-OX1-5 promoters were amplified as following. A 945 bp DNA fragment containing the FMO GS-OX1 promoter was PCR amplified from genomic DNA with the primers 5#-GGCTTAAUG GCGAAGAAATGGTCGTTGC-3# and 5#-GGTTTAAUTTATT TTATTAAATTTCTATGATATGTTTGATTTTCA-3#. A 2.2 kb DNA fragment containing the FMO GS-OX2 promoter was PCR amplified from genomic DNA with the primers 5#-GGCTTAAU-CAAGGGTAAGGGATGCTTGA-3# and 5#-GGTTTAAUATA TTTGAACTTTATGGTATGGTGG-3#. A 2 kb DNA fragment containing the FMO GS-OX3 promoter was PCR amplified from genomic DNA with the primers 5#-GGCTTAAUTCTCACGTCA CGCCTCTACCCTC-3# and 5#-GGTTTAAUATTTTGTCAAAT CTTAATAATAGTAG-3#. A 2 kb DNA fragment containing the FMO GS-OX4 promoter was PCR amplified from genomic DNA with the primers 5#-GGCTTAAUTCCCCCTCATAAATTTCTT CC-3# and 5#-GGTTTAAUTTTTCAAAGTTTTGAATG-3#. A 2.3 kb DNA fragment containing the FMO GS-OX5 promoter was PCR-amplified from genomic DNA with the primers 5#-GGCTTA AUTGAGCCTCGTCTTGCTCATA-3# and 5#-GGTTTAAUCT TTTTTGTGTGATGATGATGC-3#. The FMO GS-OX1-5 promoters were then individually ligated to the 5# end of the fused GFP-GUS gene in the plant expression vector pCAMBIA 3300 NLS-GFP-GUS by the USER method (Nour-Eldin et al., 2006) . pCAMBIA 3300 NLS-GFP-GUS is generated from the original vector pCAMBIA 3300 by adding the NLS (nuclear localization signal) and coding sequence of the fusion gene GFP-GUS with User cloning sites (Nour-Eldin et al., 2006) for the promoters. In the resulting constructs, the fused gene GFP-GUS is driven by the respective FMO GS-OX1-5 promoters.
To identify the subcellular localization of FMO GS-OX1, two constructs were made. The first one is 35S::FMO GS-OX1 -YFP (yellow fluorescent protein). The FMO GS-OX1 coding sequence without a stop codon was amplified from cDNA with the genespecific primers 5#-GGCTTAAUATGGCACCAACTCAAAA-CACAATC-3# and 5#-GGTTTAAUTGATTCGAGGAAATAA-GAAG-3#. Total plant RNA was isolated with Trizol and the firststrand cDNA was synthesized using the iScriptä cDNA synthesis kit (Bio-Rad). The FMO GS-OX1 coding sequence was then cloned into the vector pCAMBIA 2300 35S C YFP using the USER method as previously described (Nour-Eldin et al., 2006). The resulting construct 35S::FMO GS-OX1 -YFP can overexpress FMO GS-OX1 tagged with a C-terminal YFP. The second construct is Pro::FMO GS-OX1 -YFP. Genomic DNA of the FMO GS-OX1 gene including the upstream sequence, which is presumably the entire promoter and the 5#-untranslated region followed by the structural gene (without the stop codon), the YFP protein-coding sequence, and the 3#-untranslated region of FMO GS-OX1 was amplified. Because genomic DNA of FMO GS-OX1 is too long, it is divided into two pieces and amplified separately. The above four DNA fragments were then fused and cloned to the targeting plant expression vector pCAMBIA 2300 u (Nour-Eldin et al., 2006) by the USER fusion method (Geu-Flores et al., 2007) . The resulting construct Pro::FMO GS-OX1 -YFP expresses FMO GS-OX1 protein with a C-terminal YFP under the control of the FMO GS-OX1 native promoter. The upstream sequence of the FMO GS-OX1 promoter was amplified with the primers 5#-GGCTTAAU GGCGAA-GAAATGGTCGTTGCGCT-3# and 5#-ACCTCGTUATTGAAT GGACCAGGAACTCTG-3#.
The genomic structural gene of FMO GS-OX1 was amplified with the primers 5#-AACGAGGUAATGTTCCATTCAACTTGAGA-3# and 5#-ACCATTGATUCGAGGAAATAAGAAGGATGA-GAACT-3#. The coding sequence of YFP was amplified with the primers 5#-AATCAATGGUGAGCAAGGGCGAGGA-3# and 5#-ATTACTTGUACAGCTCGTCCATGCCGA-3#. The 3#-untranslated region was amplified with the primers 5#-ACAAG-TAAUGATGATCTGCGACAAATATTGTCCAA-3# and 5#-GG TTTAAUATGAACATAAATAAGAGTATCAACTTTAAGTT ACTGGA-3#.
Western blot
To detect the fusion protein in transgenic plants with the construct 35S::FMO GS-OX1 -YFP and Pro::FMO GS-OX1 -YFP, whole protein extracts from the two transgenic plants were subjected to western blot analysis. Tobacco leaves were homogenized with extraction buffer comprising 5% SDS, 2% (v/v) 2-mercaptoethanol, 2 mM phenylmethylsulphonyl fluoride, and 0.1 M TRIS-HCl, pH 8.5, followed by incubation at 95°C for 5 min. The homogenate was centrifuged and the soluble fraction was concentrated. For western blot analysis, the protein extracts were separated by SDS-PAGE, blotted onto a membrane, and detected with anti-YFP antibody according to the manufacturer's instructions.
Heterologous expression
The coding sequence of the fusion gene FMO GS-OX1 -YFP was amplified from the construct 35S::FMO GS-OX1 -YFP and then cloned into the Escherichia coli expression vector pBAD-TOPO. The resulting construct and a negative control (empty pBAD-TOPO vector) were transformed into the E. coli strain TOP 10 (Invitrogen). Production of the fusion protein was performed according to the manufacturer's recommendation; it was induced with 0.02% arabinose followed by growth at 28°C, 250 rpm for 2 h. An E. coli spheroplast enzymatic assay was performed as previously described (Hansen et al., 2007) . Protein western blot analysis was performed as described above.
GFP detection
Image acquisitions were conducted on a Leica SP2 using either 320 (NA 0.7) or 363 (NA 1.2) dipping lenses. For GFP detection, the 488 nm laser was used for excitation and the photomultiplier was set to detect in the 525-565 nm range. To detect autofluorescence from the chloroplasts, the 488 nm laser was also used for excitation, and detection was in the 680-700 nm range. A UV laser (364 nm) was used to visualize supportive tissue and conductive tissue in the flower stalks; detection was in the 425-485 nm range. Microscopy was carried out in xy mode with a line averaging of eight scans in order to lower the contribution of unspecific random noise seen as background. The pictures were acquired as sequential frame by frame scans, meaning that the different laser channels were collected one by one where the frames alternated between 364 nm excitation and 488 nm excitation.
Laser power was minimized to lower the risk of photodamage and photobleaching to cells while still having a clear fluorescent signal. Microscope data were processed using Leica Lite (Leica Microsystems) and Image J (Staal et al., 2004) .
GUS detection
The histochemical detection of GUS expression was performed essentially as described (Jefferson et al., 1987) . Plant materials were cut and incubated in substrate solution at 37°C for 12 h followed by removal of chlorophyll by submerging the samples in 96% ethanol. The samples were examined and photographed using a stereo microscope (Leica MZ FL III) or a research microscope (Leica DM R). GUS-stained flower stalk material was embedded in agarose as described (Peleman et al., 1989) . Sections were made on an ultramicrotome (Leica VT1000S) and images were obtained using a research microscope.
Results

Tissue and cellular localization of FMO GS-OX1 expression
To investigate the spatial expression pattern of FMO GS-OX1 , transgenic plants carrying the construct FMO GS-OX1 Pro::GFP-GUS expressing the fused GFP-GUS gene under the control of the FMO GS-OX1 promoter were generated. Promoter activity was detected as GFP fluorescence or as a GUS signal in living plant material. In seedlings, GFP fluorescence was detected in vascular tissue throughout the radicle, hypocotyl, cotyledons, and foliage leaves (Fig. 1A) . In fully grown leaves, fluorescence was found in the vascular tissue including the mid-vein and some major side veins (Fig. 1B) . A less intense signal was observed in epidermal cells (Fig. 1C) . In flower stalks, the GFP signal was found in part of the phloem and the xylem (Fig. 1G) . Fluorescence was observed at the junction between the flower bud and flower stalk (Fig. 1D ), but very little fluorescence was detected in petals, sepals, stigma, and anthers. Dense fluorescence was detected in vascular tissue of silique walls (Fig. 1E ) and seed funicles which are the junctions between the silique septum and seed ( Fig. 1F-1 , F-2). Because of the autofluorescence, the GFP signal in roots was ambiguous. However, GUS staining showed that the FMO GS-OX1 promoter is active in the junction between the lateral root and its primary root (Fig. 2E) . The expression pattern of FMO GS-OX1 by GUS analysis was in full agreement with the results of GFP fluorescence detection ( Supplementary Fig. S1 available at JXB online).
Throughout the whole plant, high FMO GS-OX1 expression activity was detected in almost all the nodes, for example between the leaf and flower stalk ( Fig. 2A) , flower and flower stalk, or silique and flower stalk (Fig. 2B, C) , and also the seed funicles (Fig. 2D) . In roots, FMO GS-OX1 promoter activity was restricted to the junction between the lateral root and its primary root (Fig. 2E) .
Sections of fresh flower stalk tissue were examined by confocal microscopy. A FMO GS-OX1 fluorescence signal was observed throughout most parts of the phloem (Fig. 3A, B) which means that the FMO GS-OX1 promoter might be active in all phloem cell types: sieve elements, companion cells, and phloem parenchyma cells. In the xylem, GFP fluorescence was detected in the parenchyma cells (Fig. 3A, B) . Fluorescence was also observed in an endodermis-like cell layer which is a single layer of cells between the outer cortex and the inner cylinder (Fig. 3B, C) . Within flower stalks, between the endodermis-like layer and the vascular bundles there are usually 1-6 cells called S-cells. This cell type appears very large in both cross-sections and longitudinal sections. These cells have been suggested to be the predominant storage sites for glucosinolates (Koroleva et al., 2000) . In the present experiments, no fluorescence was detected in these S-cells (Fig. 3D, E) which indicates that FMO GS-OX1 was not expressed in S-cells.
Subcellular localization of FMO GS-OX1
FMO GS-OX1 was chosen as an example to identify the subcellular localization of FMO GS-OX s. Two constructs 35S::FMO GS-OX1 -YFP and Pro::FMO GS-OX1 -YFP encoding the FMO GS-OX1 -YFP fusion protein under the control of the 35SCaMV promoter and the FMO GS-OX1 promoter, respectively, were transformed into tobacco leaf by the Agrobacterium infiltration method (Sparkes et al., 2006) . At the same time, the coding sequence of FMO GS-OX1 -YFP was subcloned and heterologously expressed in E. coli as described previously (Hansen et al., 2007) . In both the transgenic tobacco leaves and transgenic E. coli spheroplasts, a protein of ;79 kDa which is the predicted size of a fusion between FMO GS-OX1 (52 kDa) and YFP (27 kDa) was detected by western blot using anti-YFP antibody (Fig. 4A) . Recombinant protein expressed in E. coli was detected to be active for S-oxygenation. Experiments proved that the YFP signal in the transgenic plants was from FMO GS-OX1 -YFP fusion protein and that FMO GS-OX1 is still functional after fusion with YFP, hence the fluorescence detected represented the localization of functional FMO GS-OX1 .
Five days after infiltration, YFP signals were detected in epidermal cells. YFP-expressing cells transformed with the construct 35S::FMO GS-OX1 -YFP showed fluorescent signals located in the ER seen as a clear fluorescent network structure (Fig. 4B ) and those transformed with construct Pro::FMO GS-OX1 -YFP accumulated fluorescence in the cytosol (Fig. 4B ). Comparing expression controlled by the 35S promoter with expression controlled by the FMO GS-OX1 promoter, the latter should resemble native FMO GS-OX1 protein.
It is hypothesized that the ER-located fluorescence signal in 35S::FMO GS-OX1 -YFP transgenic cells stems from the newly synthesized protein being transported through the ER or it could simply be accumulated in the ER due to heavy overexpression. In order to confirm this hypothesis, leaves transformed with 35S::FMO GS-OX1 -YFP were treated with 5% cycloheximide which is expected to inhibit de novo protein biosynthesis without affecting intercellular protein trafficking. At 5 h after the treatment, ;80% of the epidermal cells no longer showed fluorescence in the ER. Instead, a more intensive signal was detected in the cytosol (Fig. 4B ). This suggests that during the treatment, FMO GS-OX1 -YFP protein was relocated to the cytosol and therefore less or no fluorescence was left in the ER due to the inhibition of de novo protein synthesis. Fluorescence in the cytosol became stronger by accumulation of the relocated protein.
Nine days after the infiltration, fluorescence in leaves transformed with 35S::FMO GS-OX1 -YFP was observed in the cytosol instead of in the ER. This result indicates that FMO GS-OX1 may be stored in the cytosol, and the ER seems to be involved in biosynthesis or transportation of FMO GS-OX1.
Tissue and cellular localization of FMO GS-OX2-5 expression
Activity/localization analysis similar to that for FMO GS-OX1 was performed for the FMO GS-OX2-5 genes. Comparable distribution patterns for these genes were found, albeit with some small variations in the leaf and root (Fig. 5) . Like FMO GS-OX1 , FMO GS-OX3-5 were expressed in vascular tissues throughout the whole plant. FMO GS-OX2 was only detectable in leaf and flower stalk but not in silique and root, possibly due to its low expression level (Li et al., 2008) .
In flower stalks, all FMO GS-OX s showed an expression pattern in the vascular bundles like that observed for FMO . No obvious spatial expression difference among the FMO GS-OX s was observed, except for the level of gene expression. Most of the expression variation was detected in leaves where FMO GS-OX1-5 were all expressed in the vascular tissue but with different patterns (Fig. 5A ).
Discussion
Breakdown products of aliphatic glucosinolates are considered to have cancer-preventive properties and to be involved in plant defence. These diverse biological activities are greatly dependent on the structure of the glucosinolates side chain; hence, it is interesting to locate where in the plants the side chain modification reaction take place.
In the current work the spatial expression pattern of FMO GS-OX1-5 which encode enzymes catalysing side chain modification of aliphatic glucosinolates is outlined. Location of the five genes was studied in whole plants; that is, in different organs, tissues, and cells, and at the subcellular level.
Expression pattern of FMO GS-OX1-5 and integrated localization of glucosinolate metabolism FMO GS-OX1-5 were detected mainly in the vascular tissue especially in phloem cells, which is in agreement with previous reports concerning other glucosinolate biosynthetic and regulatory genes (Mikkelsen et al., 2000; Reintanz et al., 2001; Tantikanjana et al., 2001; Grubb et al., 2004; Levy et al., 2005; Skirycz et al., 2006) . The present investigations provide evidence to back up the conclusion that phloem is the centre of glucosinolate biosynthesis and regulation. Furthermore, glucosinolates are suggested to be accumulated in high amounts in so-called S-cells (Koroleva et al., 2000) where no FMO GS-OX genes are expressed (Fig. 3D, E) . Myrosinases, used for glucosinolate degradation, were reported to be specifically located in idioblasts, which are morphologically differentiated cells, located either adjacent to vascular bundles or, to a lesser extent, in guard cells (Andreasson et al., 2001; Husebye et al., 2002; Thangstad et al., 2004) ; hence, expression of FMO GS-OX s is separated from that of myrosinases. Altogether, the present research supports a previous idea that glucosinolate biosynthesis, storage, and hydrolysis are spatially separated (Kelly et al., 1998) .
A high level of expression of FMO GS-OX s was detected throughout the whole plant in all the nodes (Fig. 2) . This expression pattern has been mentioned for other biosynthetic genes; for example, CYP79F1 and IQD1 which were found to be expressed in seed funicles (Reintan et al., 2001; Levy et al., 2005) , and AOP2 which was observed in the flower stalk-silique junction (Kern, 2007) . These junctions could serve as another active site of glucosinolate biosynthesis in addition to the phloem.
Beside vascular bundle and node localization, FMO GS-OX s also have some specialized features and are found in leaf epidermal cells and in endodermis-like cells in the flower stalk which is new for the glucosinolate biosynthetic pathway. This indicates that at least methylsulphinylalkyl glucosinolates, which are catalysed by FMO GS-OX s, require transport of intermediates between one cell type and another. So far, little is known about glucosinolate short-distance transport. Considering the protective function of epidermal cells and probably also for the endodermis-like cells, the catalysed products of FMO GS-OX s are possibly involved in the defence against herbivores or pathogens.
FMO GS-OX1-5 were identified as a cluster of genes that encode the conversion of methylthioalkyl to methylsulphinylalkyl glucosinolates (Hansen et al., 2007; Li et al., 2008) . Catalysis by FMO GS-OX1-4 is independent of the chain length of methylthioalkyl glucosinolates, while FMO GS-OX5 is specific toward the long chain 8-methylthiooctyl glucosinolate (Li et al., 2008) . The present study showed that FMO GS-OX5 was expressed throughout the vascular tissue in leaves and roots (Fig. 5) , while expression of FMO GS-OX1-4 was more specific (Fig. 5) . Phylogenetic analysis suggests a common FMO GS-OX ancestor of FMO GS-OX5 and a precursor of FMO GS-OX1-4 (Li et al., 2008) . The present research indicated that a FMO GS-OX ancestor with a broad range of fairly non-specific substrates for catalysis and broad spatial expression could probably have been duplicated into FMO GS-OX5 , which kept its broad spatial expression, and the FMO GS-OX1-4 precursor which retained the broad range of substrates for catalysis. At the same time, the FMO GS-OX s might have been subfunctionalized (partitioning the original function) by gaining either a specific spatial expression pattern (FMO GS-OX1-4 ) or a specific catalysing property (FMO GS-OX5 ). Of course the true direction of these processes would require the identification and biochemical characterization of FMO GS-OX ancestral genes.
Spatial expression pattern of FMO GS-OX s might affect the glucosinolate profile by determining the access of enzymes to their substrates It was previously determined that although FMO GS-OX1-4 had similar catalytic properties, slight glucosinolate profile differences were detected in leaves between the different FMO GS-OX1-4 T-DNA knockout mutants (Hansen et al., 2007; Li et al., 2008) . Consistent with this, the spatial expression patterns of FMO GS-OX1-4 were quite similar, but slight differences could be observed across organs, especially in leaves. This indicated that the spatial expression pattern of the FMO enzymes might affect the profile of their substrate glucosinolates. Among the five FMO GS-OX s, FMO GS-OX4 was the only one without expression in the mid-vein of the leaf (Fig. 5A) . Previously, glucosinolates were reported to be concentrated in the mid-vein and the peripheral part of leaves (Shroff et al., 2008) . The lack of expression in the mid-vein and peripheral leaf area could lead to separation of FMO GS-OX4 and its substrate, which could explain why no altered glucosinolate profile was seen in the FMO GS-OX4 knock-out mutant in spite of its high expression level (Li et al., 2008) . In contrast, FMO GS-OX2 showed a very low level of expression, and only in the mid-vein (Fig. 5A) , where glucosinolates are usually concentrated. FMO GS-OX2 showed significant glucosinolate alteration in its knock-out mutant (Li et al., 2008) . This may be explained by the easy access of this enzyme to its substrate. Altogether, the present experiments showed that the spatial expression pattern of FMO GS-OX s is related to the glucosinolate profile. FMO GS-OX catalyis is dependent on not only gene expression levels but also the spatial expression pattern.
Subcellular localization of FMO GS-OX s
Analysis of the FMO GS-OX1 -YFP fusion protein showed that FMO GS-OX1 is a cytosolically expressed protein (Fig. 4B) . This result is supported by the fact that this protein does not carry an N-terminal extension as do its chloroplast and mitochondrial counterparts, which is in accordance with predictions by LOCtree and SubLoc which both suggested that this enzyme lacked a target sequence and could be located in the cytosol. In addition, there is no indication of the presence of a candidate N-terminal or the highly conserved C-terminal peroxisomal targeting signal, so FMO GS-OX1 is possibly exclusively distributed in the cytosol. Considering the high sequence homology and similar catalytic function, the other FMO GS-OX s are likely to be located in the cytosol too. FMO GS-OX4 was predicted to be located in the cytosol by WolFPSORT, and FMO S-OX5 was also predicted to be located in the cytosol by LOCtree. However, further experimental evidence is still needed to confirm that S-oxygenation reactions of aliphatic glucosinolate biosynthesis catalysed by FMO GS-OX2-5 do take place in the cytosol.
Though FMO GS-OX1 was demonstrated to be a cytosolic protein, the fluorescence signal of FMO GS-OX1 -YFP was detected in the ER of the cells in 35S::FMO GS-OX1 -YFP transgenic tobacco during the first few days of transient expression. The overexpression of FMO GS-OX1 -YFP controlled by the 35S promoter resulted in large amounts of protein production; therefore it is easily observed in the process of biosynthesis or transportation. However, after Fig. 6 . Compartmentation of aliphatic glucosinolate biosynthesis. Biosynthesis of aliphatic glucosinolates involves reactions in the cytosol, chloroplast, and ER. The initial deamination of methionine catalysed by BCAT4 occurs in the cytosol. The MAM enzymes (MAMs) and probably other side chain elongation enzymes are in the chloroplast. The subsequent reactions of core structure formation catalysed by monooxygenases CYP79F1, CYP79F2, CYP83A1, etc. take place in the cytosol interface of the ER. Subsequent reactions are catalysed by enzymes located in the cytosol, including sulphotransferases which catalyse the final step of glucosinolate core structure formation. For secondary modification, formation of methylsulphinylalkyl glucosinolate is catalysed by FMO GS-OX s and generation of alkenyl glucosinolates is catalysed by AOP2 that both are soluable proteins. treatment with cycloheximide, an inhibitor of de novo protein synthesis, the YFP signal was no longer detected in the ER but was found in the cytosol. This could indicate that the ER might be involved in the early phase of biosynthesis or transportation of FMO GS-OX1 . It is generally accepted that the ER is the site of secretory and integral membrane protein synthesis (Walter and Lingappa, 1986; Gö rlich et al., 1992) . Recent studies demonstrating that mRNAs encoding cytosolic proteins are represented on ERbound polyribosomes indicate a global role for the ER in cellular protein synthesis , and research has suggested that the ER membrane also contributes a substantial portion of newly synthesized proteins to the cytosol ; the present results are in line with these results, but from a plant perspective.
Integrated cellular compartmentation of the aliphatic glucosinolate biosynthetic pathway
Compartmentation of FMO GS-OX1 which catalyses side chain modification of S-oxygenation, together with results from previous studies, leads to a localization map of the aliphatic glucosinolate biosynthetic pathway (Fig. 6) .
The first steps of aliphatic glucosinolate biosynthesis, chain elongation, and the initial transamination of methionine by BCAT4 are carried out in the cytosol (Schuster et al., 2006) . The catalytic product is then transported to the chloroplasts (Textor et al., 2007) and undergoes further steps of chain elongation catalysed by MAMs enzymes, among others (Fig. 6 ). There might be cycles between the cytosol and chloroplast for multiple steps of chain elongation (Schuster et al., 2006) . The methionine derivatives are exported to the cytosol and then form the core structure catalysed by a series of enzymes CYP79F1, CYP79F2, CYP83A1, GGP1, C-S lyase, UGT74B1 and STs' (Reintanz et al., 2001; Chen et al., 2003; Naur et al., 2003; Gen-Flores et al., 2009) . Most of glucosinolate core structure formation enzymes are found in the ER and they are likely to assemble into multienzyme complexes on the cytosolic surface of the ER (Reintanz et al., 2001; Chen et al., 2003; Naur et al., 2003; Grubb and Abel, 2006) . Subsequent reactions are catalysed by enzymes located in the cytosol including the sulphotransferases ST5c and ST5b which catalyse the last step of glucosinolate core structure formation (Klein et al., 2006) . For the final steps of aliphatic glucosinolate biosynthesis, i.e. side chain modification, FMO GS-OX1 which catalyses the first S-oxygenation reaction is located in the cytosol. There is also evidence that the following step, i.e. generation of alkenyl glucosinolates catalysed by AOP2, occurs in the cytosol (Kern, 2007) .
In summary, the FMO GS-OX1-5 expression pattern shows an integrated view of the localization of aliphatic glucosinolate biosynthesis in organs, tissues, cells, and at the subcellular level. It is suggested that the expression pattern of FMO GS-OX s determine the access of catalysing enzymes and their substrates and therefore can affect the glucosinolate profile.
Supplementary data
Supplementary data are available at JXB online. Figure S1 . Expression pattern of FMO GS-OX1 detected by the FMO GS-OX1 promoter-directed GUS expression. (A) Seedling; (B) leaf; (C) cross-section of a flower stalk; (D) silique wall; (E) opened silique; (F) root.
